Close Menu
News JournosNews Journos
  • World
  • U.S. News
  • Business
  • Politics
  • Europe News
  • Finance
  • Turkey Reports
  • Money Watch
  • Health
Editors Picks

Investigation Launched into Former FBI Director’s Threatening Post Regarding Trump

May 15, 2025

DOGE Allocates $51M in Grants for Shea Butter, Pineapple Juice, and Other Initiatives

April 7, 2025

Trump Pledges to Revive Columbus Day Nationally

April 27, 2025

Trump’s Plan to Enhance U.S. Investment Appeal

May 5, 2025

Trump Administration Unable to Deport Family of Colorado Attack Suspect

June 4, 2025
Facebook X (Twitter) Instagram
Latest Headlines:
  • UVA President Resigns Amid Federal Investigation
  • China’s CATL Expands Global Presence, Impact on Battery Market Explored
  • 3.5 Tons of Cocaine Seized from ‘Narco Sub’ in Pacific Ocean Off Mexico
  • Luxury Doomsday Bunkers Set to Open in 2026 for Wealthy Clients
  • Supreme Court Rules in Favor of Parents Challenging Children’s Books on Gender Identity and Sexuality
  • AI-Generated Videos Spread Misinformation on Iran-Israel Conflict, Researchers Warn
  • Diddy’s Lawyer Calls Prosecution a “Fake Trial” in Closing Argument
  • Kılıçdaroğlu Urges Intellectuals to Challenge the Status Quo
  • Fenerbahçe Title Celebration Targeted by Transphobic Smear Campaign Amid Drag Performance
  • New York Advances Nuclear Power Plant Initiative to Achieve Clean Energy Targets
  • Norway’s Crown Princess Son Faces Rape and Sexual Assault Charges
  • Afghan Ally Detained by ICE Following Immigration Court Appearance
  • Families of French Prisoners in Iran Express Concerns Over Their Location
  • Democratic Donors Show Hesitation Toward Harris’ California Governor Campaign
  • California Governor Sues Media Company for Defamation
  • Smugglers Receive Decades-Long Sentences After 53 Migrant Deaths in Texas Truck Incident
  • Nike Stock Rises Following Stronger-Than-Expected Q4 2025 Earnings
  • Two Charged with Murder Following Wedding Shooting in France, Leaving Bride Dead and Groom Injured
  • Supreme Court Restricts Judges’ Use of Nationwide Injunctions in Birthright Citizenship Case
  • Iran’s Foreign Minister Acknowledges ‘Serious Damage’ to Nuclear Sites Amid Official Denial
Facebook X (Twitter) Instagram
News JournosNews Journos
Subscribe
Friday, June 27
  • World
  • U.S. News
  • Business
  • Politics
  • Europe News
  • Finance
  • Turkey Reports
  • Money Watch
  • Health
News JournosNews Journos
You are here: News Journos » U.S. News » Doctor Warns of Smuggling of ‘Zombie Drug’ Xylazine into U.S.
Doctor Warns of Smuggling of 'Zombie Drug' Xylazine into U.S.

Doctor Warns of Smuggling of ‘Zombie Drug’ Xylazine into U.S.

News EditorBy News EditorMarch 25, 2025 U.S. News 7 Mins Read

A significant public health concern has emerged as the tranquilizer known as xylazine, commonly nicknamed the “zombie drug,” is increasingly being smuggled across the U.S. southern border. Originally intended for veterinary use, this potent drug has found its way into illicit drug markets and is often mixed with fentanyl, exacerbating the ongoing opioid crisis. Experts are urging urgent action to combat its spread and mitigate its dangerous effects on users.

Article Subheadings
1) Understanding Xylazine and its Use
2) Rising Trends in Xylazine Usage
3) Impact on Public Health
4) Regulatory Responses to the Challenge
5) The Path Ahead: Combating the Crisis

Understanding Xylazine and its Use

Xylazine is primarily recognized as a tranquilizer for animals, particularly in veterinary medicine. Dr. Joseph Friedman, who has extensively researched the drug, notes that it was historically confined to veterinary practices, with users having accessed it mainly through theft from veterinary supplies. Over the years, however, the scope of its use has shifted dramatically. The drug has started to infiltrate human drug markets, often used illicitly as a mixing agent with opiates like fentanyl to enhance the drug’s euphoric effects. The impact of xylazine on the human body is particularly concerning, as it can induce a state of deep sedation, which has led to its alarming nickname, the “zombie drug.”

Rising Trends in Xylazine Usage

The evolution of xylazine’s presence in the illicit drug market has been rapid. Beginning in the 2010s, the drug overturned its initial reputation as a veterinary tranquilizer to become a substance of abuse. As indicated in a recent study by Friedman, there is a marked uptick in the presence of xylazine, particularly in regions like Tijuana and southern California. The findings suggest that a significant portion of the drug is now being manufactured abroad and is entering the U.S. through smuggling operations at the border. This transition denotes a crucial turning point, as xylazine is not only being stolen but is now being purposefully trafficked into the country.

Friedman emphasizes that the mix of xylazine with fentanyl is becoming increasingly prevalent, creating dangerous combinations that contribute to the growing overdose crisis. The integration of xylazine into the opioid supply chain means that users may be unaware they are consuming it alongside fentanyl, a potent opioid, leading to higher fatality rates due to overdose.

According to recent data, in over 98% of xylazine detections in overdose cases, it appeared together with fentanyl. This innovative misuse and blending of drugs foreshadow significant implications for treatment and policy initiatives across the country. As more users seek out fentanyl laced with xylazine, the landscape of addiction and overdose continues to evolve.

Impact on Public Health

The intertwining of xylazine and fentanyl has provoked growing concern among public health officials. The drug itself can leave users in a debilitating state, characterized by severe sedation, impaired motor skills, and an insensitivity to pain. More alarmingly, xylazine does not respond to naloxone, a critical medication used for reversing opioid overdoses. This facet renders it especially hazardous, as even interventions that might save lives in the case of fentanyl overdoses fall short with xylazine-related incidents.

Xylazine-related deaths have surged significantly, with a report from the Centers for Disease Control and Prevention (CDC) indicating that its prevalence in opioid fatalities increased dramatically, from just 2.9% in early 2019 to 10.9% by mid-2022. The implication of these statistics cannot be overstated; as users unconsciously combine xylazine and fentanyl, they become trapped in a cycle of dependability that has devastating physical and psychological effects. The broader ramifications on healthcare systems and first responders are equally sobering, as resources become stretched thin in the face of this emerging dual threat.

Regulatory Responses to the Challenge

Given the escalating crisis surrounding xylazine, regulatory and governmental bodies are beginning to take action. In 2023, the Drug Enforcement Administration (DEA) issued a public safety alert regarding xylazine, categorizing it as a crucial and imminent threat amid the ongoing drug crisis. The DEA’s alert elucidated that xylazine is making the already perilous landscape of fentanyl even deadlier, warning that the drug has been mixed with fentanyl in 48 out of the 50 states.”

Furthermore, the increasing awareness around xylazine has led to calls for stricter regulations on its importation and distribution. Recently, the U.S. Food and Drug Administration (FDA) focused on limiting the import of veterinary xylazine to prevent misuse. Officials across various states are advocating for legislative action to combat the horrifying trend of xylazine use. Some lawmakers propose codifying stricter penalties for violations related to the theft or distribution of xylazine, while others are proposing initiatives aimed at increasing awareness among healthcare providers about the risks associated with this dangerous drug.

The Path Ahead: Combating the Crisis

The battle against the proliferation of xylazine and its integration with fentanyl is an ongoing struggle that necessitates multi-faceted approaches. As evidenced by the rising rates of overdose deaths associated with both substances, comprehensive strategies emphasizing prevention, intervention, and education are paramount. Healthcare providers, law enforcement, and community organizations must collaboratively devise programs that not only address immediate crises but also advocate for long-term solutions. Increased access to treatment programs is essential to support those grappling with addiction, while also raising awareness about the dangers of mixing xylazine with other substances.

Additionally, continuous monitoring and research into the dynamics of xylazine in the drug market are crucial for developing effective responses. It is imperative that medical professionals receive support in identifying and managing xylazine-related cases promptly. Overall, the path forward involves robust governmental actions, impactful community programs, and ongoing public health initiatives aimed at eradicating the influence of xylazine and protecting individuals from its devastating effects.

No. Key Points
1 Xylazine, known as the “zombie drug,” is increasingly being smuggled into the U.S. from abroad.
2 The combination of xylazine and fentanyl poses a significant risk to public health, complicating overdose responses.
3 Drug-related fatalities involving xylazine have surged in recent years, notably impacting opioid overdose statistics.
4 Regulatory measures are being implemented to address the challenges posed by xylazine’s illicit use.
5 A comprehensive approach, including prevention and intervention strategies, is necessary to combat the xylazine crisis.

Summary

The emergence of xylazine as a growing concern represents a critical juncture in the ongoing battle against the opioid crisis in the United States. As the drug continues to infiltrate the illicit market, both public health outcomes and regulatory responses are pivotal in addressing the escalating danger it poses. Stakeholders from various sectors must collaborate to implement comprehensive educational programs and robust health interventions to protect vulnerable populations from addiction and overdose, all while striving to completely eradicate xylazine’s influence in the drug landscape.

Frequently Asked Questions

Question: What is xylazine?

Xylazine is a tranquilizer initially developed for veterinary use, primarily to sedate animals. It has gained notoriety as a substance of abuse when mixed with other drugs, particularly fentanyl.

Question: Why is xylazine considered dangerous?

Xylazine poses unique dangers, particularly because it induces deep sedation and does not respond to naloxone, the medication typically used to reverse opioid overdoses. Its mixing with fentanyl significantly increases the risk of fatal overdoses.

Question: What are the signs of xylazine use?

Signs of xylazine use can include intense drowsiness, slowed heart rate, and erratic behaviors. Users may also experience skin sores, as xylazine constricts blood vessels and reduces oxygen flow, leading to severe consequences on health.

Congress Crime Doctor drug Economy Education Elections Environmental Issues Healthcare Immigration Natural Disasters Politics Public Policy smuggling Social Issues Supreme Court Technology U.S warns White House Xylazine Zombie
Share. Facebook Twitter Pinterest LinkedIn Email Reddit WhatsApp Copy Link Bluesky
News Editor
  • Website

As the News Editor at News Journos, I am dedicated to curating and delivering the latest and most impactful stories across business, finance, politics, technology, and global affairs. With a commitment to journalistic integrity, we provide breaking news, in-depth analysis, and expert insights to keep our readers informed in an ever-changing world. News Journos is your go-to independent news source, ensuring fast, accurate, and reliable reporting on the topics that matter most.

Keep Reading

U.S. News

UVA President Resigns Amid Federal Investigation

5 Mins Read
U.S. News

California Governor Sues Media Company for Defamation

6 Mins Read
U.S. News

NYPD Arrests Six During Protest Outside Tech Firm Office

6 Mins Read
U.S. News

Tesla Manufacturing Chief Omead Afshar Dismissed by Elon Musk

5 Mins Read
U.S. News

Rubrik Acquires AI Startup Predibase for Over $100 Million

5 Mins Read
U.S. News

Louisiana Offers Extensive Incentives to Attract Major Data Center Investment

6 Mins Read
Mr Serdar Avatar

Serdar Imren

News Director

Facebook Twitter Instagram
Journalism Under Siege
Editors Picks

Newborn Trump Accounts Promoted by Presidents and CEOs

June 9, 2025

Jewish Tesla Owner Shocked by Activist Drawing Swastika on Cybertruck

March 16, 2025

California Man Charged with Threatening Trump on Facebook

June 3, 2025

Expert Critiques AG’s Legal Actions Against Trump as “Laughable”

April 17, 2025

Mexican Cartel Cocaine Tester Extradited to the U.S.

February 25, 2025

Subscribe to News

Get the latest sports news from NewsSite about world, sports and politics.

Facebook X (Twitter) Pinterest Vimeo WhatsApp TikTok Instagram

News

  • World
  • U.S. News
  • Business
  • Politics
  • Europe News
  • Finance
  • Money Watch

Journos

  • Top Stories
  • Turkey Reports
  • Health
  • Tech
  • Sports
  • Entertainment

COMPANY

  • About Us
  • Get In Touch
  • Our Authors
  • Privacy Policy
  • Terms and Conditions
  • Accessibility

Subscribe to Updates

Get the latest creative news from FooBar about art, design and business.

© 2025 The News Journos. Designed by The News Journos.

Type above and press Enter to search. Press Esc to cancel.

Ad Blocker Enabled!
Ad Blocker Enabled!
Our website is made possible by displaying online advertisements to our visitors. Please support us by disabling your Ad Blocker.